Skip to main content
Home HMS signature

HMS Active Malignancy Vascular Access Toolkit

Evidence-based vascular access practices—including appropriate device selection, dwell times, and staff education—help reduce complications, improve patient safety, and support high-quality, cost-effective cancer care.

  1. Home
  2. Quality Initiatives
  3. PICC Initiative
  4. HMS Active Malignancy Vascular Access Toolkit

 

For patients with active malignancy, complications from vascular access devices can significantly impact outcomes and increase healthcare costs. Implementing evidence-based guidelines, educating staff on appropriate device selection and dwell times, and using decision support tools tailored to cancer care can reduce complications, enhance safety, and improve care efficiency. Engaging stakeholders and promoting consistent practices supports high-quality, cost-effective treatment.

  • Develop Institutional Guidelines for Vascular Access Use in Patients with Cancer

    Establishing evidence-based guidelines for vascular access promotes consistent, high-quality care and reduces complications like infections and thrombosis. These protocols enhance patient safety, support staff education, and provide a foundation for ongoing quality improvement through data-driven refinement.

    Learn more about this recommendation
  • Use a Decision Support Tool to Assess Device Appropriateness Prior to Insertion

    A decision support tool helps clinicians choose the most appropriate vascular access device by considering cancer type, therapy duration, and risk factors, reducing complications and improving patient outcomes. It also promotes consistent, high-quality care, supports clinician education, and enhances resource efficiency through fewer unnecessary procedures and device changes.

    Learn more about this recommendation
  • Assessment of Duration of Vascular Access Device Use in Patients with Cancer

    Educating staff on appropriate dwell times for various vascular access devices promotes evidence-based practice and improves care quality. Using clear, evidence-based guidelines and engaging stakeholders helps ensure optimal device selection, enhancing patient safety and reducing costs.

    Learn more about this recommendation
  • Decrease Use of Triple Lumen Vascular Access Devices in Patients with Cancer

    Providing educational materials on the risks of complications from multi-lumen vascular access devices and promoting appropriate lumen selection supports evidence-based care and improves patient outcomes. Implementing clear guidelines, encouraging staff feedback, and engaging stakeholders fosters safer practices, reduces unnecessary lumen use, and enhances both safety and cost-efficiency.

    Learn more about this recommendation
  • Reduce Complications Related to Vascular Access Devices in Patients with Cancer

    Complications from vascular access devices can harm patient outcomes and drive up healthcare costs. By implementing evidence-based guidelines and educating staff on best practices, healthcare providers can reduce complications, enhance patient safety, improve care quality, and achieve significant cost savings.

    Learn more about this recommendation
  • Device Management in Patients with Cancer

    Complications from vascular access devices can negatively affect patient outcomes and increase healthcare costs. Standardizing maintenance practices through evidence-based guidelines and staff education enhances patient safety, reduces complications, and improves care efficiency.

    Learn more about this recommendation